Cocaine-associated chest pain

American Journal of the Medical Sciences

Volumn 324, Issue 1, 2002, Pages 37-44

  Erwin, Michael B ^a   Deliargyris, Efthymios N ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; CREATINE KINASE MB; ESMOLOL; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HALOPERIDOL; HEPARIN; LABETALOL; PHENTOLAMINE; PROPRANOLOL; VERAPAMIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COCAINE DEPENDENCE; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; MALE; PATHOPHYSIOLOGY; PROGNOSIS; THORAX PAIN;

EID: 0036317920     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200207000-00006     Document Type: Article

References (49)

1. The management of cocaine-associated myocardial ischemia
2. Cardiovascular complications of cocaine use
3. Evaluation of patients with chest pain after cocaine use
4. Cocaine: The newest risk factor for cardiovascular disease
5. Hemodynamic and electrophysiological actions of cocaine
6. The effects of acute and chronic cocaine use on the heart
7. Cocaine use and acute myocardial infarction
8. Cardiac complications of cocaine abuse
9. Cocaine-induced coronary-artery vasoconstriction
10. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: Enhanced vasoconstriction at sites of significant stenoses
11. Cocaine-induced myocardial infarction in patients with normal coronary arteries
12. Simultaneous acute thrombosis of two major coronary arteries following intravenous cocaine use
13. Effects of cocaine on human platelets in healthy subjects
14. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts
15. Activation of human platelets by cocaine
16. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis
17. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: An alternative mechanism of cocaine-associated coronary vasospasm and thrombosis
18. Cerebrovascular complications of the use of the ’crack’ form of alkaloidal cocaine
19. Early afterdepolarizations and triggered activity induced by cocaine
20. Electrophysiologic effects of intranasal cocaine
21. Cocaine induced coronary artery dissection
22. Cocaine-Induced Pneumopericardium
23. Dilated cardiomyopathy and cocaine abuse
24. Reversible cardiomyopathy associated with cocaine intoxication
25. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population
26. Effects of the intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans
27. Left ventricular hypertrophy associated with chronic cocaine abuse
28. Management of cocaine-induced cardiovascular complications
29. Acute cardiac events temporally related to cocaine abuse
30. Cardiac ramifications of cocaine abuse
31. Assessment of cocaine use in patients with chest pain syndromes
32. Cocaine and chest pain: Clinical features and outcome of patients hospitalized to rule out myocardial Infarction
33. Predictors of coronary artery disease in patients with cocaine-associated myocardial infarction
34. Prospective multicenter evaluation of cocaine associated chest pain
35. Recurrent coronary vasoconstriction caused by intranasal cocaine: Possible role for metabolites
36. Myocardial ischemia during cocaine withdrawal
37. Cardiac troponin I and T concentrations in patients with cocaine-associated chest pain
38. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin
39. Nitroglycerin in the treatment of cocaine associated chest pain-Clinical safety and efficacy
40. How to manage acute MI when cocaine is the cause
41. Potentiation of Cocaine-induced coronary vasoconstriction by beta-adrenergic blockade
42. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications
43. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans
44. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil
45. Use of phentolamine for cocaine induced myocardial ischemia
46. Thrombolytic therapy and cocaine-associated acute myocardial infarction
47. Cocaine associated myocardial infarction: Clinical safety of thrombolytic therapy
48. Cocaine-associated myocardial infarction
49. Chest pain associated with cocaine: An assessment of prevalence in sub-urban and urban emergency departments